These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1972216)

  • 1. Modern vaccines. Progress towards vaccines we need and do not have.
    Robbins A
    Lancet; 1990 Jun; 335(8703):1436-8. PubMed ID: 1972216
    [No Abstract]   [Full Text] [Related]  

  • 2. The global vaccine enterprise: a developing world perspective.
    Shin SI
    Nat Med; 1998 May; 4(5 Suppl):503-5. PubMed ID: 9585198
    [No Abstract]   [Full Text] [Related]  

  • 3. The politics of vaccine production.
    Sauri MA
    Md Med; 2005; 6(1):19-22. PubMed ID: 15869102
    [No Abstract]   [Full Text] [Related]  

  • 4. Win-win interactions between the public and private sectors.
    Batson A
    Nat Med; 1998 May; 4(5 Suppl):487-91. PubMed ID: 9585192
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccine candidates for poor nations are going to waste.
    Kaslow DC; Black S; Bloom DE; Datla M; Salisbury D; Rappuoli R
    Nature; 2018 Dec; 564(7736):337-339. PubMed ID: 30560957
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction of vaccines into the Third World.
    Widdus R
    C R Acad Sci III; 1999 Nov; 322(11):999-1010. PubMed ID: 10646097
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination lags behind in middle-income countries.
    Berkley S
    Nature; 2019 May; 569(7756):309. PubMed ID: 31089234
    [No Abstract]   [Full Text] [Related]  

  • 8. For vaccines, the future is now.
    Saldarini RJ
    Nat Med; 1998 May; 4(5 Suppl):485-7. PubMed ID: 9585191
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccines for the world: major challenges for the future.
    Lambert PH
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 2():122-6. PubMed ID: 9561647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of vaccines of an assured quality.
    Magrath DI
    Vaccine; 1992; 10(13):952-3. PubMed ID: 1471418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccines, the modern state and societies].
    Moulin AM
    Med Sci (Paris); 2007 Apr; 23(4):428-34. PubMed ID: 17433235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines and the world of child health.
    Lancet; 2009 Oct; 374(9699):1393. PubMed ID: 19854355
    [No Abstract]   [Full Text] [Related]  

  • 13. WHO expectation and industry goals.
    Vandersmissen W
    Vaccine; 2001 Feb; 19(13-14):1611-5. PubMed ID: 11166883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine visions and their global impact.
    Bloom BR; Widdus R
    Nat Med; 1998 May; 4(5 Suppl):480-4. PubMed ID: 9585190
    [No Abstract]   [Full Text] [Related]  

  • 15. Make vaccine coverage a key UN health indicator.
    Berkley S
    Nature; 2015 Oct; 526(7572):165. PubMed ID: 26450023
    [No Abstract]   [Full Text] [Related]  

  • 16. Modern vaccines. Practice in developing countries.
    Hall AJ; Greenwood BM; Whittle H
    Lancet; 1990 Mar; 335(8692):774-7. PubMed ID: 1969519
    [No Abstract]   [Full Text] [Related]  

  • 17. Obstacles to developing vaccines for the Third World.
    Robbins A; Freeman P
    Sci Am; 1988 Nov; 259(5):126-33. PubMed ID: 3212439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the World Health Organization. State of the World's Vaccines and Immunizations.
    JAMA; 2002 Nov; 288(20):2532. PubMed ID: 12444848
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-benefit evaluations of vaccination programmes.
    Cutting WA
    Lancet; 1980 Sep; 2(8195 pt 1):634-5. PubMed ID: 6107418
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunization needs a technology boost.
    Berkley S
    Nature; 2017 Nov; 551(7680):273. PubMed ID: 29144479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.